Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis EP News Bureau Mar 15, 2023 A humanised IgG4 monoclonal antibody, Copellor (Ixekizumab) is designed to specifically target IL-17A, a protein that plays a role…
